A Single-Center, Randomized, Observer Blind, Vehicle- and Comparator-controlled Trial to Evaluate the Antipsoriatic Efficacy and Safety of Topical Formulations of C-82 in a Psoriasis Plaque Test

Trial Profile

A Single-Center, Randomized, Observer Blind, Vehicle- and Comparator-controlled Trial to Evaluate the Antipsoriatic Efficacy and Safety of Topical Formulations of C-82 in a Psoriasis Plaque Test

Completed
Phase of Trial: Phase I/II

Latest Information Update: 26 Oct 2015

At a glance

  • Drugs C 82 (Primary) ; Betamethasone dipropionate; Calcipotriol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors PRISM Pharma Co
  • Most Recent Events

    • 19 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 30 Jun 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov
    • 30 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top